Published in Invest Ophthalmol Vis Sci on January 25, 2012
Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis. JAMA Ophthalmol (2013) 1.48
Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clin Infect Dis (2012) 1.22
Topical corticosteroids as adjunctive therapy for bacterial keratitis. Cochrane Database Syst Rev (2014) 1.14
Nocardia keratitis: clinical course and effect of corticosteroids. Am J Ophthalmol (2012) 0.93
Corneal Collagen Cross-linking for Treatment of Non-healing Corneal Ulcers. J Ophthalmic Vis Res (2015) 0.79
Role of steroids in the treatment of bacterial keratitis. Clin Ophthalmol (2016) 0.78
Topical Corticosteroids in the Management of Bacterial Keratitis. Curr Ophthalmol Rep (2013) 0.77
In vitro antimicrobial activity of a novel compound, Mul-1867, against clinically important bacteria. Antimicrob Resist Infect Control (2015) 0.77
Pattern recognition receptors in microbial keratitis. Eye (Lond) (2015) 0.76
Cytotoxic clinical isolates of Pseudomonas aeruginosa identified during the Steroids for Corneal Ulcers Trial show elevated resistance to fluoroquinolones. BMC Ophthalmol (2014) 0.76
Efficacy of systemic vitamin C supplementation in reducing corneal opacity resulting from infectious keratitis. Medicine (Baltimore) (2014) 0.75
Management and treatment of contact lens-related Pseudomonas keratitis. Clin Ophthalmol (2012) 0.75
Challenges of corneal infections. Expert Rev Ophthalmol (2016) 0.75
Bioactive Antimicrobial Peptides as Therapeutics for Corneal Wounds and Infections. Adv Wound Care (New Rochelle) (2017) 0.75
Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol (1997) 4.52
Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol (2007) 2.19
Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol (2011) 2.09
Risk factors and causative organisms in microbial keratitis. Cornea (2008) 2.01
The steroids for corneal ulcers trial: study design and baseline characteristics. Arch Ophthalmol (2011) 1.76
Trends in the etiology of infectious corneal ulcers at the F. I. Proctor Foundation. Cornea (2004) 1.48
Indecision about corticosteroids for bacterial keratitis: an evidence-based update. Ophthalmology (2002) 1.43
Aetiological diagnosis of microbial keratitis in South India - a study of 1618 cases. Indian J Med Microbiol (2007) 1.41
Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India. Indian J Ophthalmol (2010) 1.40
Corticosteroids for bacterial corneal ulcers. Br J Ophthalmol (2008) 1.40
Topical steroids in the treatment of central and paracentral corneal ulcers. Br J Ophthalmol (1990) 1.36
Rationale for adjunctive topical corticosteroids in bacterial keratitis. Arch Ophthalmol (2009) 1.31
The case against the use of steroids in the treatment of bacterial keratitis. Arch Ophthalmol (2009) 1.29
Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: double-blinded randomized clinical trial. Can J Ophthalmol (2011) 1.28
A rat model of bacterial keratitis. Effect of antibiotics and corticosteroid. Arch Ophthalmol (1985) 1.08
Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res (1995) 1.08
Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res (1993) 0.90
Conrad Berens Lecture. The management of infectious keratitis as we approach the 21st century. CLAO J (1998) 0.86
Recurrence of microbial keratitis concomitant with antiinflammatory treatment in an animal model. Cornea (1992) 0.85
Anti-inflammatory effectiveness in the cornea of topically administered prednisolone. Invest Ophthalmol (1974) 0.82
Anti-inflammatory effectiveness of topically administered corticosteroids in the cornea without epithelium. Invest Ophthalmol (1975) 0.79
Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study. PLoS One (2009) 3.66
Outbreak of Fusarium keratitis in soft contact lens wearers in San Francisco. Arch Ophthalmol (2006) 3.33
An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med (2003) 3.32
Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial. Lancet (2009) 3.17
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology (2007) 3.11
Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol (2007) 3.00
Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch Ophthalmol (2010) 2.98
Clinical Neonatal Seizures are Independently Associated with Outcome in Infants at Risk for Hypoxic-Ischemic Brain Injury. J Pediatr (2009) 2.96
Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology (2007) 2.41
Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA (2006) 2.29
Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial. Lancet (2011) 2.20
Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2). Nat Genet (2006) 2.20
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol (2013) 2.17
Antenatal and intrapartum risk factors for seizures in term newborns: a population-based study, California 1998-2002. J Pediatr (2008) 2.15
Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma. JAMA (2008) 2.12
Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol (2011) 2.09
Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun (2005) 2.04
When the time comes to talk about HIV: factors associated with diagnostic disclosure and emotional distress in HIV-infected children. J Acquir Immune Defic Syndr (2002) 2.01
Spontaneous corneal hydrops and perforation in keratoconus and pellucid marginal degeneration. Cornea (2003) 2.00
Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation. Pediatr Crit Care Med (2003) 1.98
Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Arch Ophthalmol (2007) 1.96
Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA (2004) 1.90
Evidence for two flagellar stators and their role in the motility of Pseudomonas aeruginosa. J Bacteriol (2005) 1.86
Socioeconomic disparities in the use and success of fertility treatments: analysis of data from a prospective cohort in the United States. Fertil Steril (2011) 1.85
Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. JAMA (2009) 1.79
The steroids for corneal ulcers trial: study design and baseline characteristics. Arch Ophthalmol (2011) 1.76
Increased plasminogen activator inhibitor-1 concentrations in bronchoalveolar lavage fluids are associated with increased mortality in a cohort of patients with Pseudomonas aeruginosa. Anesthesiology (2007) 1.73
Identifying postelimination trends for the introduction and transmissibility of measles in the United States. Am J Epidemiol (2014) 1.69
Reduction and return of infectious trachoma in severely affected communities in Ethiopia. PLoS Negl Trop Dis (2009) 1.68
How reliable are tests for trachoma?--a latent class approach. Invest Ophthalmol Vis Sci (2011) 1.65
Effect of statin drugs and aspirin on progression in open-angle glaucoma suspects using confocal scanning laser ophthalmoscopy. Clin Experiment Ophthalmol (2007) 1.62
Recurrent postnatal infections are associated with progressive white matter injury in premature infants. Pediatrics (2008) 1.60
Genetic analysis of patients with Fuchs endothelial corneal dystrophy in India. BMC Ophthalmol (2010) 1.59
Real-time polymerase chain reaction in the diagnosis of acute postoperative endophthalmitis. Am J Ophthalmol (2012) 1.53
International results with the Boston type I keratoprosthesis. Ophthalmology (2012) 1.53
Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. Ophthalmology (2013) 1.51
Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis. JAMA Ophthalmol (2013) 1.48
A rationale for continuing mass antibiotic distributions for trachoma. BMC Infect Dis (2007) 1.48
Evaluation of the relationship between ablation diameter, pupil size, and visual function with vision-specific quality-of-life measures after laser in situ keratomileusis. Arch Ophthalmol (2007) 1.47
Clinical signs predict 30-month neurodevelopmental outcome after neonatal encephalopathy. Am J Obstet Gynecol (2004) 1.46
Practice patterns in the management of fungal corneal ulcers. Cornea (2009) 1.43
Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. Am J Ophthalmol (2007) 1.42
Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas? J Infect Dis (2003) 1.42
Arterial switch with full-flow cardiopulmonary bypass and limited circulatory arrest: neurodevelopmental outcome. J Thorac Cardiovasc Surg (2004) 1.41
Efficacy of transport media use versus direct inoculation of blood agar plates in the microbiologic evaluation of experimental Streptococcus pneumoniae keratitis. Cornea (2003) 1.40
Laboratory model of bursting pressures of femtosecond laser-assisted penetrating keratoplasty wounds using novel pattern designs. Br J Ophthalmol (2012) 1.39
Synchrony dual-optic accommodating intraocular lens. Part 2: pilot clinical evaluation. J Cataract Refract Surg (2007) 1.38
Expression of innate and adaptive immune mediators in human corneal tissue infected with Aspergillus or fusarium. J Infect Dis (2011) 1.38
Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma. Br J Ophthalmol (2006) 1.37
Nocardia endophthalmitis after cataract surgery: clinicomicrobiological study. Am J Ophthalmol (2005) 1.37
Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial. PLoS Med (2010) 1.37
Childhood mortality in a cohort treated with mass azithromycin for trachoma. Clin Infect Dis (2011) 1.36
When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries. PLoS Negl Trop Dis (2009) 1.36